Edward A. Copelan
#153,548
Most Influential Person Now
Edward A. Copelan's AcademicInfluence.com Rankings
Edward A. Copelanphilosophy Degrees
Philosophy
#8586
World Rank
#11996
Historical Rank
Logic
#5619
World Rank
#7031
Historical Rank
Download Badge
Philosophy
Why Is Edward A. Copelan Influential?
(Suggest an Edit or Addition)Edward A. Copelan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hematopoietic stem-cell transplantation. (2006) (1411)
- Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen (1987) (446)
- Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. (2010) (372)
- Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. (1987) (322)
- Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. (2014) (276)
- Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms (2014) (270)
- SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS (2011) (250)
- The biology and treatment of acute lymphoblastic leukemia in adults. (1995) (224)
- Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. (2009) (193)
- Evidence for possible involvement of an elastolytic serine protease in aspergillosis (1993) (190)
- The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. (2010) (181)
- Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. (1991) (179)
- SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. (2012) (179)
- Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. (2017) (177)
- A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. (2006) (174)
- Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. (2010) (165)
- Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. (2014) (162)
- Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. (2006) (160)
- Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. (2013) (141)
- Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. (2008) (131)
- Hemolysis following intravenous immune globulin therapy (1986) (126)
- A scheme for defining cause of death and its application in the T cell depletion trial. (2007) (124)
- Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research. (2005) (114)
- Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. (2011) (114)
- Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis (2012) (102)
- Elevated pretransplant ferritin is associated with a lower incidence of chronic graft‐versus‐host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation (2009) (100)
- Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission (2002) (99)
- Plotting summary predictions in multistate survival models: probabilities of relapse and death in remission for bone marrow transplantation patients. (1993) (98)
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease (2013) (97)
- The mechanism of retrovirus suppression of human T cell proliferation in vitro. (1983) (89)
- HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. (1994) (89)
- Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis. (2017) (87)
- Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. (2008) (81)
- Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. (1990) (81)
- Apoptosis: a general comment (1991) (75)
- Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. (2019) (67)
- Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research (2019) (66)
- Platelet-mediated bleeding caused by broad-spectrum penicillins. (1987) (64)
- p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia (2011) (64)
- Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes. (2015) (62)
- Conditioning for allogeneic marrow transplantation in patients with lymphohematopoietic malignancies without the use of total body irradiation. (1992) (61)
- Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease. (1997) (58)
- Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. (2013) (58)
- Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome. (2016) (57)
- HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. (2008) (57)
- Allogeneic hematopoietic cell transplantation; the current renaissance. (2019) (52)
- Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation (2014) (51)
- Decitabine Maintains Hematopoietic Precursor Self-Renewal by Preventing Repression of Stem Cell Genes by a Differentiation-Inducing Stimulus (2010) (51)
- Concise Review: The Role of Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia (2012) (51)
- Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure (2018) (49)
- Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation (2009) (48)
- Hematopoietic stem cell transplantation in adults with acute myeloid leukemia. (2008) (48)
- Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma. (2008) (48)
- p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies. (2012) (48)
- Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. (2009) (45)
- Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia. (2015) (45)
- Vitamin D level after allogeneic hematopoietic stem cell transplant. (2011) (44)
- Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. (1996) (42)
- Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome. (2013) (41)
- Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study (2013) (40)
- Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation. (2006) (39)
- Survival following allogeneic transplant in patients with myelofibrosis. (2020) (39)
- Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation (2012) (38)
- Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy (2020) (38)
- Can G-CSF cause leukemia in hematopoietic stem cell donors? (2011) (38)
- Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS (2012) (36)
- Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. (2010) (34)
- Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres (2011) (34)
- Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDS (2011) (33)
- SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia (2014) (33)
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. (2016) (33)
- Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma (2020) (33)
- Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT). (2012) (32)
- Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy. (1991) (32)
- Psoralen plus ultraviolet A (PUVA) in the treatment of chronic graft versus host disease: preliminary experience in standard treatment resistant patients. (1992) (30)
- Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. (2004) (30)
- Absolute lymphocyte count at day 28 independently predicts event‐free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia (2012) (29)
- Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: A simple method using day 1 CD34+ cell yield (2011) (29)
- Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival. (2018) (29)
- The non‐relapse mortality rate for patients with diffuse large B‐cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls (2011) (29)
- Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia (2012) (28)
- Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY. (1993) (28)
- Indications for marrow transplantation in chronic myelogenous leukemia. (1989) (28)
- Allogeneic marrow transplantation in non-Hodgkin's lymphoma. (1990) (27)
- ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE (2013) (27)
- Marrow transplantation following busulfan and cyclophosphamide for chronic myelogenous leukaemia in accelerated or blastic phase (1989) (27)
- Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA‐identical sibling donor allogeneic hematopoietic cell transplantation (2015) (26)
- Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT (2011) (26)
- Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non‐Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide (2010) (26)
- Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. (1995) (25)
- Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance. (2002) (25)
- Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia. (1992) (24)
- High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma. (2007) (24)
- Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation. (1989) (24)
- Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma (2011) (24)
- Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2). (1993) (23)
- Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients (2010) (22)
- Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia (2021) (22)
- Chronic myelogenous leukemia. (2004) (22)
- Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. (2018) (22)
- Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia (2011) (22)
- Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. (2013) (21)
- Evaluation of CYP2C19 Genotype‐Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant (2020) (21)
- Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation. (2014) (21)
- Marrow transplantation following busulfan and cyclophosphamide in multiple myeloma. (1988) (21)
- Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation (2014) (20)
- Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. (2020) (20)
- BU- vs TBI-based conditioning for adult patients with ALL (2011) (19)
- Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation (2008) (19)
- Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. (2012) (19)
- High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia (2005) (19)
- Increasing Use of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Age 70 Years and Older: A CIBMTR Study of Trends and Outcomes (2016) (18)
- Conditioning regimens for allogeneic bone marrow transplantation. (1992) (18)
- High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation. (2006) (18)
- Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma. (2017) (18)
- BONE MARROW TRANSPLANTATION WITHOUT TOTAL‐BODY IRRADIATION IN PATIENTS AGED 40 AND OLDER (1989) (17)
- Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials. (2017) (17)
- Clinical Outcomes of Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum Undergoing Autologous HCT: a CIBMTR Retrospective Analysis (2012) (17)
- Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin (2020) (17)
- A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia. (2010) (17)
- A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma (2009) (17)
- Controlled trial of orally administered immunoglobulin following bone marrow transplantation. (1994) (17)
- Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia (2010) (16)
- Hematopoietic stem cell transplantation in multiple myeloma. (2007) (16)
- Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome (2015) (16)
- A comparison of the effects of mezlocillin and carbenicillin on haemostasis in volunteers. (1983) (15)
- A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse. (2010) (15)
- Allogeneic bone marrow transplantation for leukemia using chemotherapy as conditioning: 6-year results of a single institution trial. (1991) (15)
- Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients. (2019) (15)
- Thalidomide-induced fulminant hepatic failure. (2007) (15)
- Peripheral Immunotype Correlates with Minimal Residual Disease Status and Is Modulated by Immunomodulatory Drugs in Multiple Myeloma. (2019) (15)
- Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia. (2009) (15)
- Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype. (2011) (15)
- Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors. (2021) (14)
- Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged ≥50 years compared to younger adults with low-risk disease (2003) (14)
- Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia (2012) (14)
- Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT. (1993) (14)
- Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites (2015) (14)
- Providing personalized prognostic information for adult leukemia survivors. (2013) (14)
- OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia (2010) (14)
- Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations (2016) (13)
- Autologous stem cell transplantation for non-Hodgkin's lymphoma. (2003) (13)
- Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants. (2010) (13)
- Influence of graft-versus-host disease on outcome following allogeneic transplantation with radiation-free preparative therapy in patients with advanced leukemia. (1996) (13)
- Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent. (1989) (13)
- Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. (2020) (13)
- Diffuse alveolar hemorrhage following gemtuzumab ozogamicin (2005) (12)
- 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation (2008) (12)
- Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant (2019) (12)
- Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy. (1996) (12)
- Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. (1996) (12)
- Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. (2015) (11)
- Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS. (2020) (11)
- Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation (2011) (10)
- Are backup BM harvests worthwhile in unrelated donor allogeneic transplants? (2010) (10)
- Non-Cytotoxic Differentiation Therapy Based On Mechanism of Disease Produces Complete Remission in Myelodysplastic Syndromes (MDS) with High Risk Cytogenetics (2012) (10)
- A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients. (2020) (10)
- Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation. (2009) (10)
- Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL) (2011) (10)
- Race and intensity of post-remission therapy in acute myeloid leukemia. (2011) (10)
- Acute Myeloid Leukemia: When to Transplant in First Complete Remission (2010) (9)
- Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades. (2019) (9)
- Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes: lingering uncertainties and emerging possibilities. (2015) (9)
- Levine Cancer Institute Approach to Pandemic Care of Patients With Cancer. (2020) (9)
- Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation (2004) (9)
- An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis (2021) (8)
- Patient Reported Financial Toxicity in Acute Leukemia (2018) (8)
- Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. (2020) (8)
- Oral Administration of IgG in Marrow Transplant Recipients (1988) (8)
- Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission (2010) (8)
- Time from Diagnosis to Treatment Initiation Predicts Survival in Acute Myeloid Leukemia (AML). (2007) (8)
- Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report (2019) (8)
- Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation (2021) (7)
- Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation (2013) (7)
- Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B‐cell lymphoma (2021) (7)
- Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer. (2015) (7)
- Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection (2017) (7)
- Therapeutic Dose Monitoring of Busulfan is Associated with a Reduction in Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation. (2020) (7)
- Prolonged remission of accelerated phase Philadelphia chromosome negative chronic myeloid leukemia following autologous recovery of normal hematopoietic elements after busulfan/cyclophosphamide and allogeneic marrow transplantation. (1992) (6)
- Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days (2018) (6)
- Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia (2008) (6)
- Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation. (2017) (6)
- A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse (2009) (6)
- Chronic myelogenous leukemia. (2005) (6)
- Comparison of Cyclosporine and Methotrexate with Cyclosporine and Mycophenolate Mofetil for Gvhd Prophylaxis in Myeloablative Allogeneic Bone Marrow Transplantation. (2008) (5)
- Risk Factors and Outcomes for Relapse after Autologous Stem Cell Transplantation for Hodgkin Lymphoma. (2007) (5)
- Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients. (2021) (5)
- The Molecular and Cytokine Profile of Triple-Negative (JAK2 V617F, JAK2 exon 12, MPL negative) Myelofibrosis, a Myeloproliferative Neoplasm with Distinct Clinico-Pathologic Characteristics (2012) (5)
- Elevated Pretransplant Serum Ferritin in Autologous Stem Cell Transplant. (2007) (5)
- Prognostic Impact of Elevated Pretransplant Serum Ferritin in Allogeneic Hematopoietic Stem Cell Transplantation. (2007) (5)
- Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation. (2007) (5)
- Impact of allogeneic hematopoietic stem cell transplant (HSCT) on patients harboring the spliceosome mutation SRSF2. (2013) (4)
- Experience with sandoglobulin in bone marrow transplantation. (1986) (4)
- Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed (2019) (4)
- Analysis of Readmission After Autologous HCT: Predictive Factors and Clinical Consequences (2010) (4)
- Lymphokine activated killer (LAK) activity in lymphoproliferative disorders. (1989) (4)
- Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for CML: Refined HLA-matching shows more GVHD but not less relapse Blood Marrow (2010) (4)
- HSCT: navigating the journey ahead. (2015) (4)
- Second autologous bone marrow transplantation in Hodgkin's disease. (1993) (4)
- Bortezomib + MEC (Mitoxantrone, Etoposide, Cytarabine) for Relapsed/ Refractory Acute Myeloid Leukemia: Final Results of an Expanded Phase 1 Trial (2014) (4)
- Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) (2016) (4)
- Prior Therapy with DNA Methyltransferase Inhibitors (DNMTI) Predicts for Lower Remission Rates and Worse Survival In Secondary Acute Myeloid Leukemia Patients (sAML) Receiving Remission Induction Therapy (2010) (4)
- Pharmacogenomics-guided supportive oncology: A tale of two trials. (2021) (3)
- Prevention of Severe GVHD Employing Cyclosporine in HLA-Matched Marrow Transplant for Leukemia (1988) (3)
- Evaluation of noncytotoxic DNMT 1-depleting therapy in patients with myelodysplastic syndromes (2019) (3)
- Purine Metabolism in Feline Lymphomas (1990) (3)
- Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research (2021) (3)
- Use of molecular markers to determine postremission treatment in acute myeloid leukemia with normal cytogenetics. (2015) (3)
- Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study (2015) (3)
- A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Bortezomib for Relapsed/Refractory Acute Myeloid Leukemia (2012) (3)
- A Prognostic Scoring System for Patients ≤ 60 Years of Age with Acute Lymphocytic Leukemia in First Relapse. (2008) (3)
- Alternate applications of immunoglobulin following bone marrow transplantation. (1992) (3)
- Cigarette Smoking Significantly Increases the Risk of Invasive Fungal Disease (IFD) in Acute Myeloid Leukemia (AML) Patients Undergoing Induction Chemotherapy (2011) (2)
- Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia (2010) (2)
- Peripheral Blood Hematopoietic Stem-cell Mobilization for Autologous Transplantation (2011) (2)
- Light-chain myeloma and amyloidosis (1984) (2)
- Successful Hematopoietic Stem Cell Transplantation Following a Cyclophosphamide-Containing Preparative Regimen with Concomitant Phenobarbital Administration (2012) (2)
- Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum (2011) (2)
- Incidence of Extramedullary Relapse of Acute Myeloid Leukemia Following Transplantation with Busulfan-Based Conditioning Regimens. (2004) (2)
- Navigating the nexus of MRD and novel agents in ALL. (2019) (2)
- The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis (2022) (2)
- Impact of Mutations in the Spliceosome Machinery and Ring Sideroblasts in Patients with Myeloid Malignancies Who Received Conventional Chemotherapy or Allogeneic Hematopoietic Cell Transplantation (2012) (2)
- Hypomethylating agent (HMA) treatment as a bridge to allogeneic hematopoietic cell transplantation (HCT) for relapsed/refractory acute myeloid leukemia (RR-AML). (2018) (2)
- Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases (2017) (2)
- The Role of Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) in Autologous Stem Cell Transplantation for Multiple Myeloma (2012) (2)
- Financial Toxicity Intervention Decreases Mortality in High Risk Hematologic Malignancy Patients (2020) (2)
- Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies. (1989) (2)
- Financial Toxicity Intervention Improves Quality of Life in Hematologic Malignancy Patients (2020) (2)
- Defining Central Line-Associated Blood Stream Infections Following Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome. (2012) (2)
- Use of Isavuconazole for Prophylaxis Against Invasive Fungal Infections in Allogeneic Stem Cell Transplant Patients: A Real World Experience (2018) (2)
- Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML). (2008) (2)
- Use of the Ohio state busulfan/cyclophasphamide regimen in recipients of matched unrelated donor transplants (1995) (2)
- A Phase 1 Trial of Imatinib Mesylate with Daunorubicin and Cytarabine for Patients with C-Kit Positive Relapsed AML. (2008) (2)
- Hematopoietic cell transplantation in MDS: undervalued and underutilized (2016) (2)
- Patient Reported Financial Toxicity in Myeloproliferative Neoplasms (2019) (2)
- Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia (2017) (2)
- Bone marrow purging with glucocorticoids. (1990) (2)
- NCCN Practice Guidelines for Chronic Myelogenous Leukemia. (2000) (2)
- Hematopoietic Growth Factors in the Supportive Care and Treatment of Patients with Hematologic Neoplasms (2013) (2)
- Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Versus Matched Unrelated Donor (2019) (2)
- Biological Rationale for the Favorable Clinical Outcomes of Patients Carrying SF3B1 Mutations in Myelodysplastic Syndromes with Ring Sideroblasts (2012) (2)
- Poor Mobilization of CD34+ Stem Cells Predicts Inferior Relapse and Survival Outcomes After Autologous Stem Cell Transplantation for Multiple Myeloma (2011) (2)
- Outcomes In Acute Myeloid Leukemia (AML) Patients Diagnosed with Myeloid Sarcoma with and without Bone Marrow Involvement (2010) (2)
- Pharmacologic marrow purging in murine T cell leukemia. (1988) (2)
- Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation (2021) (2)
- Comparison of Quality of Life Outcomes and Psychosocial Functioning Between Patients Undergoing Myeloablative or Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies (2011) (2)
- Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy (2022) (2)
- A Proof of Principle Clinical Trial in Myelodysplastic Syndromes of Non-Cytotoxic Differentiation Therapy with Decitabine, (2011) (1)
- Creation of a research database to comply with the HIPPA Privacy Act (2006) (1)
- Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia (2012) (1)
- Timing of High Dose Melphalan (HDM) and Outcomes for Autologous Stem Cell Transplantation (ASCT) in Patients With Multiple Myeloma (MM) (2009) (1)
- Mycophenolate Mofetil Is a Suitable Substitute for Methotrexate for Graft Versus Host Disease Prevention in Myeloablative Allogeneic Hematopoietic Cell Transplantation with Sibling Donors (2012) (1)
- Omission of Methotrexate Doses Due to Toxicity Does Not Influence the Incidence of Gvhd, Relapse, or Survival (2012) (1)
- Are Busulfan-Based Preparative Regimens Equivalent, Worse, or Better than Total Body Irradiation Regimens? (2000) (1)
- Chronic Myeloid Leukemia (CML) (2018) (1)
- Serologic Investigation of Pneumococcal Immunization of Autologous Hematopoietic Stem Cell Recipients (2014) (1)
- Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML). (2007) (1)
- CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients. (2019) (1)
- Optimizing Progenitor Cell Mobilization in Patients with Myeloma: Effect of a Pre-Emptive Day 4 Plerixafor-Based Mobilization Algorithm (2016) (1)
- Absolute Lymphocyte Count At Day 28 Independently Predicts Event-Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphocytic Leukemia (2011) (1)
- Impact of Race, Ethnicity, and Social Determinants of Heath on Outcomes for Acute Myeloid Leukemia Patients in a System with Specialized Nurse Navigation (2022) (1)
- Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide. (1993) (1)
- Improving the Odds. (2020) (1)
- Very Few Interventions after Tumor Lysis Monitoring in Patients with Chronic Lymphocytic Leukemia Who Are Started on Venetoclax in the Real-World Setting- Suggests Less Intensive Monitoring Maybe Safe for Low-Risk Patients (2021) (1)
- Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma (2017) (1)
- Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax. (2022) (1)
- Predicitve Value of Pretransplant Testing. (2004) (1)
- Risk Factors for Vancomycin Resistant Enterococcus (VRE) Infection and Its Influence On Survival After Allogeneic Hematopoietic Progenitor Cell Transplantation (aHPCT) (2012) (1)
- Impact of Lenalidomide Maintenance Therapy on Immune Polarization and Activation in Multiple Myeloma (2015) (1)
- Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia (2020) (1)
- Comparison of Outcomes Between 2-Year Survivors After Myeloablative and Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. (2009) (1)
- after allogeneic bone marrow transplantation Immunoglobulin G subclass deficiency and pneumococcal infection (2011) (1)
- CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis (2016) (1)
- Race and Intensity of Post-Remission Therapy in Acute Myeloid Leukemia (AML). (2009) (1)
- The Impact of the Major Histocompatibility Complex Class I-Related Chain a (Mica) and Human Leukocyte Antigen (HLA)-DP Mismatches on Severe Acute GVHD in Patients Receiving Allogeneic Hematopoietic Progenitor Cell Transplants (AHPCT) from Adult Unrelated Donors (2012) (1)
- Hematopoietic cell transplantation in chronic myeloid leukemia in the age of tyrosine kinase inhibitors. (2015) (1)
- Clinical Characteristics and Outcomes of AML Patients Treated with Frontline CPX 351 or HMA/Venetoclax: A Single Institution's Experience (2021) (1)
- Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial (2012) (1)
- A Review of Growth Factor Support in Bloodless Autologous Hematopoietic Stem-cell Transplant. (2019) (1)
- Fluoroquinolone Prophylaxis in Acute Myeloid Leukemia (AML) Patients Undergoing Post-Remission Chemotherapy Reduces Hospital Admission Rates (2011) (1)
- Length of Stay among Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma:Predictive Factors and Prognostic Effect. (2008) (1)
- Response to High Dose Cytarabine (HIDAC) As First Salvage for Relapsed Acute Lymphocytic Leukemia in Patients Receiving HIDAC As Initial Therapy (2011) (1)
- Radiation Treatment for Localized Prostate Cancer and the Risk of Developing Myelodysplastic Syndromes (MDS) (2011) (1)
- Hla-b44.2 directed cytotoxic t cells associated with acute graft vs host disease following unrelated marrow transplantation (1991) (1)
- New TET2, ASXL1 and CBL Mutations Have Poor Prognostic Impact In Systemic Mastocytosis and Related Disorders (2010) (1)
- Distribution of Cytogenetic Abnormalities in African American Multiple Myeloma Patients May be Unique for Different Geographic Regions (2015) (1)
- Long Term Follow-Up of Patients with Chronic Myeloid Leukemia Receiving BuCy2 as Preparation for Allotransplantation. (2006) (1)
- OlRIGINAL ARTICLE p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia (2011) (1)
- Long-Term Follow-up of a Randomized Trial Comparing Cyclosporine and Short Course Methotrexate with Cyclosporine and Mycophenolate Mofetil for Graft Versus Host Disease Prophylaxis in Myeloablative HLA-Identical Sibling Hematopoietic Cell Transplantation. (2012) (1)
- Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia (2014) (1)
- Delayed development of pulmonary toxicity syndrome following busulfan preparative therapy for allogeneic marrow transplantation (2000) (1)
- De-Escalation of Antimicrobials in Adult Hematopoietic Cell Transplantation Recipients with Febrile Neutropenia of Unknown Origin (2018) (1)
- Granulocyte stimulating-colony factor-associated splenic artery rupture (2010) (1)
- Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patients (2011) (1)
- Association of prior rituximab exposure among patients undergoing autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma with inferior outcomes in males compared with females. (2012) (0)
- Survival Trends after Allogeneic Hematopoietic Cell Transplant (HCT) in Children Less Than One-Year-Old (Infants) (2018) (0)
- Cytomegalovirus (CMV) Reactivation after T-Cell Replete Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) Correlates with Donor KIR Genotype. (2007) (0)
- A Phase 1 Trial of Imatinib Mesylate in Combination with Daunorubicin and Cytarabine for Patients for C-kit Positive Relapsed Acute Myeloid Leukemia (AML). (2007) (0)
- Self-Reported Distress Is Associated with Decreased Survival in Patients with Newly Diagnosed Acute Myeloid Leukemia (2022) (0)
- Upper respiratory tract SARS-CoV-2 viral shedding in cancer patients. (2021) (0)
- Fluorescence in Situ Hybridization (FISH) abnormalities and Baseline Clinical Features at Diagnosis in African American Multiple Myeloma Patients (2016) (0)
- Improved Mortality Prognostication for Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results From a Virtual Pediatric Systems (VPS) and Center for International Blood and Marrow Transplant Research (CIBMTR) Database Merger (2018) (0)
- Outcomes in minority patients (pt) with aggressive B cell lymphoma (BCL) if optimally managed with equal access to care and nurse navigation (NN). (2020) (0)
- Should busulfan now be part of the standard treatment for patients with acute myeloid leukemia (2014) (0)
- Autologous and allogeneic hematopoietic stem cell transplantation (HCT) in multiple myeloma (MM): a single institution experience (2000) (0)
- Pre-Transplant Hypogammaglobulinemia Influences Survival after Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT). (2007) (0)
- Long Term Survival After High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation in Metastatic Breast Cancer. (2012) (0)
- Neutropenic Fever During Stem Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Poor Survival Following Autologous Stem Cell Transplantation, (2011) (0)
- with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission (2013) (0)
- Racial Differences in Prognostic Factors and Outcomes in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (2012) (0)
- Cyclophosphamide (Cy) pharmacogenetics (PGx) in allogeneic stem cell transplant (SCT) patients (pts) receiving Cy, fludarabine, total body irradiation and post-transplant Cy (FluCyTBI-postCy). (2018) (0)
- Long-Term Cryopreservation of Autologous Stem Cell Grafts: Impact of Patient Age, Initial Collection, and Stem Cell Mobilization Regimen. (2010) (0)
- The Positive Effect of Inpatient Care-Partners During Allogeneic Bone Marrow Transplantation; A Prospective Trial (2010) (0)
- Superior Quality of Life Scores in Patients Over 60 Years of Age in Allogeneic Hematopoietic Cell Transplant. (2012) (0)
- Are Back-Up Bone Marrow Harvests of Value in Unrelated Donor Allogeneic Transplants?. (2007) (0)
- Long Term Follow Up with Etoposide Priming in Patients with Lymphoma. (2007) (0)
- Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation (2021) (0)
- Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplantation Program (2016) (0)
- Aurora Kinase Inhibition Overcomes Primary Venetoclax Failure and Leads to Synthetic Lethality in BCL2-Positive Lymphomas Via Upregulation of P53/P21/BAX Axis (2021) (0)
- AcDVP16 Induction Therapy for Acute Myeloid Leukemia (2017) (0)
- Acute Myeloid Leukemia Patients in Complete Remission with Positive Measurable Residual Disease Prior to Allogeneic Transplant Have Worse Outcomes, Similar to Active Disease Regardless of Conditioning Regimen Intensity and Post-Transplant Cyclophosphamide Administration (2021) (0)
- Relationship of minimal residual disease (MRD) in acute lymphocytic leukemia (ALL) and putative leukemia stem cells (LSCs). (2018) (0)
- Hematopoietic Stem Cell Transplantation in Philadelphia-Positive Acute Lymphoblastic Leukemia (2011) (0)
- Cytomegalovirus Infection in T Cell Replete Peripheral Blood Stem Cell Transplant with Post-Transplant Cyclophosphamide- A Single Center Experience (2016) (0)
- Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis (2022) (0)
- Treatment options in chronic myelogenous leukemia. (2002) (0)
- A man with oliguria and rib pain. (1998) (0)
- Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience (2011) (0)
- Evidence forPossible Involvement ofan Elastolytic Serine Protease inAspergillosis (1993) (0)
- Towards Response-Adaptive Changes in Induction Therapy to Improve Survival Outcomes in Transplant Eligible Multiple Myeloma Patients (2017) (0)
- Early Readmission Rates After Autologous and Allogeneic Hematopoietic Progenitor Cell Transplantation (HPCT) (2012) (0)
- Non-Relapse Mortality Exceeds Relapse Mortality Six Years After Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma. (2009) (0)
- Response and survival rates with frontline hypomethylating agent (HMAs) in favorable risk AML. (2017) (0)
- Influence of type of antecedent disorder on outcome of therapy-related AML. (2011) (0)
- CD34+ Cell Yield on Day 1 of Apheresis Predicts Total CD34+ Cell Mobilization, Neutrophil Recovery, and Survival After Autologous Stem Cell Transplantation for Lymphoma (2009) (0)
- lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute (2011) (0)
- Predictive Factors for Adverse Outcomes After Use of Donor Cell Infusion (DCI) in Patients with Relapsed Hematological Malignancies Treated with Allogeneic Hematopoietic Cell Transplantation (alloHCT) (2012) (0)
- Prognostic Significance of Ki67 Expression By Immunohistochemistry (IHC) on Bone Marrow Biopsy in Newly Diagnosed Multiple Myeloma (2017) (0)
- Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics (2010) (0)
- Should All Adult Patients with Acute Lymphoblastic Leukemia in First Remission Undergo Allogeneic Bone Marrow Transplantation (2000) (0)
- Risk factors for hospitalization for cancer patients with SARS-CoV-2 infection. (2021) (0)
- Abstract 1920: Response to hypomethylating agents based on cytidine deaminase expression, genetic polymorphisms, and NPM1 mutation status in acute myeloid leukemia (2020) (0)
- Favorable Survival Outcomes in Acute Myeloid Leukemia (AML) Patients (pts) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) without Achieving Complete Remission (CR) to Non-Intensive Chemotherapy (2020) (0)
- Analysis of Factors Influencing Skin Toxicity after Autologous Hematopoeitic Stem Cell Transplant. (2007) (0)
- Minimal Mortality from Veno-Occlusive Disease Following Busulfan-Based Preparative Regimens: A Large Single Institution Experience (2009) (0)
- Single Institution Experience with Two High-Dose Chemotherapy (HDC) Conditioning Regimens Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM). (2004) (0)
- Readmission Rates After Autologous Hematopoietic Stem Cell Transplantation (2010) (0)
- The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML). (2009) (0)
- Precision (in Language and) Medicine. (2016) (0)
- Extended follow up ot- patients with chronic myelogenous leukemia undergoing allogene1c transplantation following preparation wth busulfan and cyclophosphamide (1997) (0)
- Incidence of Late Failure Following Myeloablative Conditioning with BuCy2 and Matched Sibling Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia. (2008) (0)
- Prognostic Significance of Bone Marrow Involvement At Diagnosis and At the Time of Autologous Stem Cell Transplantation for Lymphoma Relapse (2011) (0)
- Busulfan and Cyclophosphamide has Similar Outcomes to High Dose Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation In Patients With Multiple Myeloma (2009) (0)
- Randomized Trial of Tacrolimus and Methotrexate Versus Tacrolimus, Reduced Dose Methotrexate, and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease after Myeloablative Related and Unrelated Donor Allogeneic Hematopoietic Cell Transplantation (2021) (0)
- Pathway Analysis of Molecular Mutations Can Modify Morphologic, Cytogenetic and Prognostic Risk Stratification Schemes in Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes/Myeloproliferative Neoplasms (MDS/MPN), and Secondary Acute Myeloid Leukemia (AML) (2012) (0)
- Dual Cord Blood Unit (dCBU) Transplantation Increases Short-Term Morbidity, but Has Similar Long-Term Outcome Compared to Matched Unrelated Donor (MUD) Transplantation After Myeloablative Conditioning. (2012) (0)
- Effective and Non-Cytotoxic p53 Independent Epigenetic-Differentiation Therapy In Xeno-Transplant Models of Human Acute Myeloid Leukemia (2010) (0)
- Preparative regimens in bone marrow transplantation: A panel discussion (1993) (0)
- Diagnosis of Mental Health Disorder Does Not Effect Outcome in Allogeneic Bone Marrow Transplant (2009) (0)
- Etoposide Priming in Patients with Lymphoma Improves Mobilization without An Increased Risk of Secondary Hematologic Malignancies. (2009) (0)
- Recent advances in hematopoietic cell transplantation in myelodysplastic syndrome. (2017) (0)
- Cigarette Smoking Is Associated with Increased Rates of Fungal Infection and Increased Mortality After Allogeneic Transplantation (2010) (0)
- Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma (2013) (0)
- Prognostic Significance of Tracking Dynamic Changes in Positron Emission Tomography (PET) Scan Pre and Post Autologous Stem Cell Transplant (ASCT) (2018) (0)
- 294: Predictors and Impact of Donor T-cell Chimerism in Myeloablative Allogeneic Stem Cell Transplantation (2008) (0)
- Effects of exercise on bleomycin-induced pulmonary toxicity in mice. (1986) (0)
- Autologous Stem Cell Transplant Improves Depth of Response and Outcomes in African American Patients When Compared With Caucasian Patients (2017) (0)
- Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF) (2022) (0)
- 174: Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (2008) (0)
- Superior Survival in Non-Hodgkin Lymphoma Following Autologous Stem Cell Transplantation with Intravenous Busulfan, Cyclophosphamide, and Etoposide. (2008) (0)
- Impact of Weekend Admissions on Quality of Care and Outcomes in Patients with Acute Myeloid Leukemia (AML). (2008) (0)
- Patients with SF3B1 Mutation Have Good Prognosis Even in the Presence of Other Poor Prognostic MDS Features and Have Better Outcomes During Treatment with Low Intensity Chemotherapy (2012) (0)
- Factors Predicting Efficacy and Toxicity of Post Transplantation Cyclophosphamide for Graft Versus Host Disease Prevention in Hematopoietic Cell Transplantation Recipients: Interim Data of an Ongoing Study (2022) (0)
- Results of Autotransplantation in Follicular Large-Cell Lymphoma. (2006) (0)
- Treatment options in chronic myelogenous leukemia. Authors' reply (2002) (0)
- Managing SCC of the Kidney (2019) (0)
- Impact on Pulmonary Function of Pre-Transplant Radiotherapy in Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplant (ASCT). (2008) (0)
- The Impact of Molecular Lesions in Post-Transplant Acute Myeloid Leukemia (AML) in Correlation with Cytogenetic Abnormalities, (2011) (0)
- Suppression of apoptosis by TP53 mutation contributes to resistance of acute myeloid leukemia (AML) to conventional cytotoxic treatment. Using differentiation to induce irreversible cell cycle exit in AML cells could be a p53-independent treatment alternative, however, this possibility requires eval (2011) (0)
- T-Cell Engraftment Kinetics Following Myeloablative and Nonmyeloablative Regimens for Allogeneic Hematopoietic Transplantation (2009) (0)
- Treatment With Hyper-CVAD Results In Poor Mobilization Of Peripheral Blood Stem Cells In Patients With Mantle Cell Lymphoma (2010) (0)
- Molecular Profiling of a Tumor of Unknown Origin (2006) (0)
- Birth Order Does Not Affect Outcome in HLA-Identical Sibling Transplantation. (2007) (0)
- Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics. (2007) (0)
- Intravenous Compared to Oral Busulfan with Cyclophophamide for Allogeneic Hematopoietic Progenitor Cell Transplant Conditioning for AML and MDS. (2010) (0)
- Fludarabine, but Not Mitoxantrone, Increases the Risk of a Poor Stem Cell Harvest and Treatment-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia (tMDS/AML) after Autologous Stem Cell Transplantation (ASCT) in Patients with Follicular Lymphoma (FL). (2008) (0)
- Outcomes in newly diagnosed diffuse large B cell lymphoma presenting with hepatic and/ or renal dysfunction. (2018) (0)
- Strides Toward Improving Post-Hematopoietic Progenitor Stem Cell Transplant Vaccination Compliance (2019) (0)
- Repeat Readmissions After Allogeneic Hematopoietic Progenitor Cell Transplantation (HPCT) (2012) (0)
- Central Line-Associated Blood Stream Infections Following Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Incidence, Risk Factors, and Impact On Survival (2012) (0)
- A murine model for pharmacological marrow purging. (1987) (0)
- Impact of Higher-Dose Total Body Irradiation Conditioning on Outcome of an Allogeneic Hematopoietic Cell Transplant (HCT) in the Modern Era (2017) (0)
- Low Incidence of Hemolysis, Delayed Red Cell Engraftment and Pure Red Cell Aplasia with Post Transplantation Cyclophosphamide following ABO Mismatched Non-Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation (2016) (0)
- Long-Term Follow-Up of Treatment for Acute Myeloid Leukemia with Allogeneic Hematopoetic Cell Transplantation Using BuCy2 as Preparation. (2006) (0)
- The Slope of Circulating Blast Clearance Does Not Predict Disease Relapse After Allogeneic Stem Cell Transplantation (2011) (0)
- Outcomes in Transplant Eligible Multiple Myeloma African American Patients Appear Similar to Caucasian Patients (2016) (0)
- Clonal Hematopoiesis Prevalence and Mutational Spectrum in Patients with Plasma Cell Disorders at the Time of Diagnosis and Its Impact on Clinical Features, Cardiovascular Complications, and Survival (2022) (0)
- Peripheral Blood Progenitor Cell Mobilization in Patients with Multiple Myeloma Utilizing a Reduced Fixed Dose of Plerixafor and a Unique Mobilization Algorithm is Feasible and Maximizes Day 1 Collection Yield (2016) (0)
- The T-Cell Epitope (TCE) Algorithm for Classifying HLA-DPB1 Mismatches Does Not Predict Clinical Outcomes in HSCT (2011) (0)
- OCT-2 Expression and OCT-2/BOB.1 Co-Expression Predict Prognosis in Patients with Newly Diagnosed Acute Myelogenous Leukemia. (2008) (0)
- Quality of Life and Psychosocial Functioning After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) from Matched Sibling Compared to Unrelated Donors (2012) (0)
- Low Vitamin D Levels After Allogeneic Hematopoietic Stem Cell Transplant. (2009) (0)
- Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report (2013) (0)
- Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML). (2009) (0)
- Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction (2019) (0)
- Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction (2017) (0)
- 15 Year Follow-up of ABMT for NHL: Surprisingly Favorable Outcome for Younger Adults. (2008) (0)
- 553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19 (2020) (0)
- Acute GVHD in AML and MDS Patients Receiving Matched Related Donor (MRD) Reduced-Intensity Conditioning Allogeneic Hematopoietic Progenitor Cell Transplant (RIC-AHPCT) Correlates with Major Histocompatibility Complex Class I-Related Molecule A (MICA) Gene Polymorphisms, (2011) (0)
- Diabetes Insipidus as the Initial Manifestation of Myelofibrosis (1995) (0)
- Non-Relapse Mortality Associated with Autologous Stem Cell Transplant (ASCT). (2007) (0)
- Outcomes in Obese and Overweight Acute Myeloid Leukemia (AML) Patients Receiving Chemotherapy Dosed According to Actual Body Weight (2011) (0)
- Risk Factors for 30-Day Hospital Readmission Following Myeloablative Allogeneic Stem Cell Transplantation. (2010) (0)
- Hodgkin's disease Second autologous stem cell transplant for multiply relapsed Hodgkin's disease (2002) (0)
- ong-term Outcome of Hodgkin Disease Patients ollowing High-Dose Busulfan, Etoposide, yclophosphamide, and Autologous tem Cell Transplantation (2006) (0)
- Risk Factors for 100-Day Readmission after Discharge in Allogeneic Hematopoietic Cell Transplant and Its Clinical Implications (2019) (0)
- Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients (2020) (0)
- Histone H4 Acetylation as a Prognostic Factor for Patients with Acute Lymphocytic Leukemia in First Relapse. (2008) (0)
- Comparison of Single Versus Multiple Unit Umbilical Cord Blood Transplantation for Adult Hematologic Malignancy Patients (2010) (0)
- Molecular Mutations in U2AF1 Are Most Commonly Found in Del20q Myelodysplastic Syndromes but Do Not Lead to Poor Prognosis in This Karyotypic Subtype (2012) (0)
- Platelet Engraftment in AML Patients Receiving Matched Related Donor (MRD) Allogeneic Bone Marrow Transplant (alloBMT) Correlates with Major Histocompatibility Complex Class I-Related Molecule A (MICA) Gene Polymorphisms (2009) (0)
- Non-Relapse Mortality (NRM) after Autologous Stem Cell Transplant (ASCT) Is Reduced with Stringent Follow-up Post-Transplant. (2008) (0)
- SWOG S0919: A phase II study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukemia (AML). (2013) (0)
- Survival and Time to Response with Frontline Hypomethylating Agents in AML (2018) (0)
- Lower Transplant-Related Mortality and Improved Survival for Patients with AML in First CR Receiving BuCy Compared to Cy/TBI As Myeloablative Preparation for Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR) (2012) (0)
- Pharmacokinetic-Guided Therapeutic Dose Monitoring (TDM) of Busulfan Reduces Relapse of Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (ASCT) (2019) (0)
- Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative (2020) (0)
- The relationship of cigarette smoking to invasive fungal disease (IFD) in acute myeloid leukemia (AML) patients undergoing induction chemotherapy (IC). (2010) (0)
- Serologic Investigation of Pneumococcal Immunization of Autologous (2014) (0)
- Leukemia cell mobilization: a road to eradication? (2015) (0)
- Risk Factors for the Development of Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Tranplantation (allo-HSCT) (2012) (0)
- Expression of Phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) Is Associated with An Increased Risk of Death In Acute Myeloid Leukemia. (2010) (0)
- Comparison of 200 cGy vs. 400 cGy Total Body Irradiation (TBI) When Used with Fludarabine for Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC AHSCT). (2007) (0)
- COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients (2023) (0)
- Chimerism Analysis Is Predictive of Relapse-Free Survival After Allogeneic Transplantation for MDS (2010) (0)
- Transplantation versus chemotherapy in acute leukemia. (1989) (0)
- Mechanism of deoxyadenosine plus deoxycoformycin toxicity to murine lymphoid leukemia (1986) (0)
- Impact of Myocardial Infarction On Survival in Acute Myeloid Leukemia (2012) (0)
- Multiple Unit Umbilical Cord Blood Transplantation (MU UCBT) With Total Body Irradiation, Etoposide And Antithymocyte Globulin For Adult Hematologic Malignancy Patients (2010) (0)
- When May Patients Be Considered Cured after Autografting for Hodgkin Lymphoma (2007) (0)
- Killer-Immunoglobulin-Like Receptor (KIR) Gene Polymorphism and BKV Associated Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplant Recipients (2011) (0)
- Filgrastim Plus Fixed-Dose Plerixafor is Cost-Effective in Peripheral Blood Hematopoietic Cell Mobilization in Patients with Multiple Myeloma (2016) (0)
- Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. (2023) (0)
- Incidence and Risk Factors Associated with Fatal Graft Vs Host Disease after Solid Organ Transplantation in United Network of Organ Transplant Database (2021) (0)
- Late Mortality and Relapse Following HLA-Identical Sibling Donor Marrow Transplantation for Chronic Myeloid Leukemia. (2008) (0)
- Platform Incorporating Patient Navigation, Preparative Guidelines, and Hospital at Home May Improve COVID-19 Outcomes for Patients with Myeloid Malignancies (2021) (0)
- Syngeneic vs. allotransplantation in chronic myeloid leukemia: all's well that ends well. (2005) (0)
- Identification and Validation of IMiD-14 Model Predictive of IMiD Resistance in Multiple Myeloma (2015) (0)
- Effect of Chromosomal Lesions Detected by SNP-Array Karyotyping on Survival After Allogeneic HCT for MDS and AML (2011) (0)
- Older Patients with AML Undergoing Matched Related Allogeneic Transplantation Have Significantly Older Donors but Equivalent Survival as Patients Receiving Unrelated Donor Transplants (2010) (0)
- Predictive Factors for Hospitalization After Outpatient Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Progenitor Cell Transplantation (AHPCT) (2011) (0)
- Impact of Adding Single-Dose Plerixafor Rescue to Granulocyte-Colony-Stimulating-Factor in Poorly Mobilizing Allogenic Transplant Donors on Cell Composition and Transplant Outcomes (2019) (0)
- Association between Regimen Related Toxicity and Acute-Graft-Versus-Host Disease. (2004) (0)
- 139: How Realistic is it to Expect a Fully Allele Level Matched Donor from a Search Through the NMDP? A 10 Year, Single Institution Experience (2008) (0)
- Multiple Unit Umbilical Cord Blood Transplantation with Total Body Irradiation, Etoposide and Antithymocyte Globulin for Adult Hematologic Malignancy Patients. (2009) (0)
- Platelet Transfusion Requirement during ASCT for Lymphoma Is a Powerful Prognostic Variable. (2008) (0)
- Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. (2022) (0)
- Sustained High-Dose Corticosteroid Use Does Not Independently Diminish Survival After Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (2011) (0)
- Duration of Antecedent Complete Blood Cell Count (CBC) Abnormalities Predicts Response and Survival Rates In De Novo and Secondary AML. (2010) (0)
- Days of Pheresis Needed for Harvesting CD34+ Cells for Autologous Hematopoietic Stem Cell Transplantation Is Associated with Speed of Neutrophil Recovery and the Development of Secondary AML/MDS. (2009) (0)
- Exploring Cost Savings of a Modified Plerixafor Protocol for Use in Autologous Stem Collection (2018) (0)
- Bone marrow transplant (BMT), cyclosporine (CsA), and HLA antibody production (1986) (0)
- Higher Non-Relapse Mortality with BuCyVP Compared to BuCy In Allogeneic Hematopoietic Stem Cell Transplant (2010) (0)
- Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (2013) (0)
- Prognostic Factors for Post-Transplant Outcomes in Patients with Myelodysplastic Syndromes (MDS) (2011) (0)
- Immunogenicity of Polysaccharide Pneumococcal Vaccination in Autologous Hematopoietic Stem Cell Transplantation (2012) (0)
- No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics. (2008) (0)
- Obese Patients Have Improved Survival Following Autologous Hematopoietic Stem Cell Transplantation (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edward A. Copelan?
Edward A. Copelan is affiliated with the following schools:
